Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP)

This study has been terminated.

(Study terminated due to low enrollment.)

Sponsor:

Information provided by:

Genzyme

ClinicalTrials.gov Identifier:

NCT00244257

First received: October 25, 2005

Last updated: July 29, 2009

Last verified: June 2008

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	July 2008
Estimated Primary Completion Date:	No date given